Search terms
Results 1 - 10 of 83 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 9

Aims To evaluate clinical profiles and outcomes in patients with systolic heart failure (HF) with or without diabetes, and the efficacy and safety of ivabradine (heart rate-lowering agent) with ...

European Journal of Heart Failure, Komajda, Michel, Tavazzi, Luigi, Francq, Bernard G., Böhm, Michael, Borer, Jeffrey S., Ford, Ian, Swedberg, Karl

Date : 01/12/2015 Item size : 50736 bytes

PrognosisAuthors Hsiao Shih-Hung, Corresponding authorDivision of Cardiology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, Republic of ChinaNational ...

European Journal of Heart Failure, Hsiao, Shih‐Hung, Chiou, Kuan‐Rau

Date : 01/11/2013 Item size : 157188 bytes

Granulocyte colony‐stimulating factor attenuates left ventricular remodelling after acute anterior STEMI: results of the single‐blind, randomized, placebo‐controlled multicentre STem cEll ...

European Journal of Heart Failure, Achilli, Felice, Malafronte, Cristina, Lenatti, Laura, Gentile, Francesco, Dadone, Viola, Gibelli, Giuseppe, Maggiolini, Stefano, Squadroni, Lidia, Di Leo, Claudio, ...

Date : 01/10/2010 Item size : 232530 bytes

Spinal cord stimulation is safe and feasible in patients with advanced heart failure: early clinical experience Introduction Spinal cord stimulation (SCS) is a non-pharmacological strategy comprised ...

European Journal of Heart Failure, Torre‐Amione, Guillermo, Alo, Kenneth, Estep, Jerry D., Valderrabano, Miguel, Khalil, Nashwa, Farazi, Taraneh G., Rosenberg, Stuart P., Ness, Lanitia, Gill, John

Date : 01/07/2014 Item size : 141824 bytes

Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT Tel: +33 1 42 16 55 14; Fax: +33 1 42 16 55 03; Email: ...

European Journal of Heart Failure, Komajda, Michel, Böhm, Michael, Borer, Jeffrey S, Ford, Ian, Robertson, Michele, Manolis, Athanasios J., Tavazzi, Luigi, Swedberg, Karl

Date : 01/07/2014 Item size : 155290 bytes

Tel: +49 6841 16 23372, Fax: +49 6841 16 23369, Email: Search for more papers by this author Ford Ian, Robertson Centre for Biostatistics, University of Glasgow, UKSearch for ...

European Journal of Heart Failure, Reil, Jan‐Christian, Robertson, Michele, Ford, Ian, Borer, Jeffrey, Komajda, Michel, Swedberg, Karl, Tavazzi, Luigi, Böhm, Michael

Date : 01/09/2013 Item size : 170847 bytes

Introduction Why and how patients with heart failure (HF) die is of relevance for both patients and their physicians, since various therapeutic options affect not only the duration and quality of ...

European Journal of Heart Failure, Rickenbacher, Peter, Pfisterer, Matthias, Burkard, Thilo, Kiowski, Wolfgang, Follath, Ferenc, Burckhardt, Dieter, Schindler, Ruth, Brunner‐La Rocca, Hans‐Peter

Date : 01/11/2012 Item size : 238277 bytes

In 2009, the HEAAL investigators[1] reported that losartan 150 mg/day reduced the rate of death and admissions for heart failure with reduced ejection fraction (HFREF) compared with patients ...

European Journal of Heart Failure, Pitt, Bertram

Date : 01/12/2012 Item size : 72879 bytes

Predicting adverse events during angiotensin receptor blocker treatment in heart failure: results from the HEAAL trial Introduction Optimal heart failure therapy in patients with reduced left ...

European Journal of Heart Failure, Kiernan, Michael S., Wentworth, Deborah, Francis, Gary, Martinez, Felipe A., Dickstein, Kenneth, Komajda, Michel, Zannad, Faiez, Neaton, James D., Konstam, Marvin A.

Date : 01/12/2012 Item size : 173079 bytes

The accumulated information from trials assessing management of chronic heart failure assisted by serial measurement of plasma concentrations of B-type cardiac natriuretic peptides (either BNP or ...

European Journal of Heart Failure, Richards, A. Mark

Date : 01/08/2013 Item size : 85712 bytes